← Leaderboards
Tait D Shanafelt
Mayo Clinic Rochester
$9,008,119
Attributed
$16,330,748
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,330,748 · 6
By mechanism
R01$12,345,676 · 4
RF1$3,354,111 · 1
K23$630,961 · 1
Top collaborators
- Neil E Kay13 shared
- Susan L Slager6 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Susan L Slager$16,375,515
- Amy C Degnim$9,208,153
- V. Shane Pankratz$4,461,337
- Hilal Maradit Kremers$11,722,206
- Myung Soo Park$5,027,387
Others in their field
Top investigators on “Chronic Lymphocytic Leukemia”
- David Heimbrook · Leidos Biomedical Research, Inc.$30,232,142
- Catherine Ju-Ying Wu · Broad Institute, Inc.$27,924,233
- John C Byrd · University Of Cincinnati$23,347,401
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Susan L Slager · Mayo Clinic Rochester$15,712,869
- Thomas J. Kipps · University Of California San Diego$14,051,126
Research focus
Chronic Lymphocytic LeukemiaBaseGeneticCohortInsightMutationResistanceDisease ProgressionToxic EffectAffectFollow-UpCharacteristicsInfectionPredict Clinical OutcomeImmuneCellsBloodAccountingAmericanCell CountDisease RemissionB-LymphocytesFutureCyclophosphamide
Grant awards (26)
Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)$3,354,111
RF1 · FY2025 · AG
Outcomes for CLL patients treated with novel therapy$671,624
R01 · FY2025 · CA
Outcomes for CLL patients treated with novel therapy$596,539
R01 · FY2024 · CA
Outcomes for CLL patients treated with novel therapy$614,982
R01 · FY2023 · CA
Outcomes for CLL patients treated with novel therapy$616,831
R01 · FY2022 · CA
Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)$464,153
R01 · FY2022 · AG
Outcomes for CLL patients treated with novel therapy$705,542
R01 · FY2021 · CA
Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)$666,402
R01 · FY2021 · AG
Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)$699,156
R01 · FY2020 · AG
Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)$699,296
R01 · FY2019 · AG
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia$634,568
R01 · FY2019 · CA
Predicting clinical outcome in individuals with small CLL B cell clones$584,454
R01 · FY2019 · CA
Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)$698,932
R01 · FY2018 · AG
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia$691,685
R01 · FY2018 · CA
Predicting clinical outcome in individuals with small CLL B cell clones$603,908
R01 · FY2018 · CA
Predicting clinical outcome in individuals with small CLL B cell clones$605,286
R01 · FY2017 · CA
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia$510,400
R01 · FY2017 · CA
Predicting clinical outcome in individuals with small CLL B cell clones$611,624
R01 · FY2016 · CA · contact PI
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia$511,603
R01 · FY2016 · CA · contact PI
Predicting clinical outcome in individuals with small CLL B cell clones$615,766
R01 · FY2015 · CA · contact PI
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia$542,925
R01 · FY2015 · CA · contact PI
The Role of Oxidative Stress in CLL B-cell Apoptosis$126,576
K23 · FY2010 · CA · contact PI
The Role of Oxidative Stress in CLL B-cell Apoptosis$126,378
K23 · FY2009 · CA · contact PI
The Role of Oxidative Stress in CLL B-cell Apoptosis$126,187
K23 · FY2008 · CA · contact PI
The Role of Oxidative Stress in CLL B-cell Apoptosis$126,000
K23 · FY2007 · CA · contact PI
The Role of Oxidative Stress in CLL B-cell Apoptosis$125,820
K23 · FY2006 · CA · contact PI